This presentation covers the impact pharmaceutical price controls have on drug research and development.

Intrusive and aggressive price regulation by the U.S. government could have devastating effects on the pharmaceutical market.

This paper reviews a large literature on the effects of pharmaceutical industry price controls on the organization and practices of firms.

Testimony before the House Committee on Industrial Relations for the State of Georgia on the harmful effects of a bill to enact comprehensive pharmaceutical price controls.

Pharmaceutical price controls offer short-term gains for a small proportion of patients at the cost of curtailing research that promises to bring far better therapies in the future.

Conventional wisdom that U.S. pharmaceutical companies made out well under the Obama health plan by bargaining with the White House is wrong.

Bill Clinton's proposed drug benefit for Medicare recipients is predicated on driving down the cost of drugs that elderly Americans need.

Fixing drug prices at lower levels would inevitably curtail development and distribution of new products that improve and extend life.